Literature DB >> 8980241

Autonomy of the epithelial phenotype in human ovarian surface epithelium: changes with neoplastic progression and with a family history of ovarian cancer.

H G Dyck1, T C Hamilton, A K Godwin, H T Lynch, S Maines-Bandiera, N Auersperg.   

Abstract

Epithelial ovarian carcinomas originate in the ovarian surface epithelium (OSE). In culture, OSE undergoes epithelio-mesenchymal conversion, an event mimicking a wound response, while ovarian carcinomas retain complex epithelial characteristics. To define the onset of this increased epithelial autonomy in ovarian neoplastic progression, we examined mesenchymal conversion in OSE from 25 women with no family histories (NFH-OSE) and 13 women with family histories (FH-OSE) of breast/ovarian cancer (including 8 with mutated BRCA1 or 17q linkage) and in 8 ovarian cancer lines. After 3-6 passages in monolayer culture, most NFH-OSE exhibited reduced keratin expression and high collagen type III expression. In contrast, keratin remained high but collagen expression was lower in p. 3-6 FH-OSE. This difference was lost in SV40-transformed lines, which all resembled FH-OSE. Most carcinoma lines remained epithelial and did not undergo mesenchymal conversion. In 3-dimensional (3-D) sponge culture, NFH-OSE cells dispersed and secreted abundant extracellular matrix (ECM). FH-OSE remained epithelial and did not secrete ECM. ECM production was also reduced in SV40-transformed lines. Carcinoma lines in 3-D formed epithelial cysts, aggregates and papillae and lacked ECM. Sponge contraction (a mesenchymal characteristic) was greater in NFH-OSE than in FH-OSE both before and after SV40 transformation and was absent in the cancer lines. Our results suggest that increased autonomy of epithelial characteristics is an early indicator of ovarian neoplastic progression and that phenotypic changes indicative of such autonomy are found already in overtly normal OSE from women with histories of familial breast/ovarian cancer.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8980241     DOI: 10.1002/(SICI)1097-0215(19961220)69:6<429::AID-IJC1>3.0.CO;2-6

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  26 in total

1.  Differentiation and growth potential of human ovarian surface epithelial cells expressing temperature-sensitive SV40 T antigen.

Authors:  E H Leung; P C Leung; N Auersperg
Journal:  In Vitro Cell Dev Biol Anim       Date:  2001-09       Impact factor: 2.416

2.  In vitro three-dimensional modelling of human ovarian surface epithelial cells.

Authors:  K Lawrenson; E Benjamin; M Turmaine; I Jacobs; S Gayther; D Dafou
Journal:  Cell Prolif       Date:  2009-04-24       Impact factor: 6.831

3.  Efficient introduction of genes into human ovarian surface epithelium.

Authors:  E H Leung; B R Davies; P C Leung; G T Chen; C D Roskelley; N Auersperg
Journal:  In Vitro Cell Dev Biol Anim       Date:  1997-10       Impact factor: 2.416

4.  BRAF mutation is associated with a specific cell type with features suggestive of senescence in ovarian serous borderline (atypical proliferative) tumors.

Authors:  Felix Zeppernick; Laura Ardighieri; Charlotte G Hannibal; Russell Vang; Jette Junge; Susanne K Kjaer; Rugang Zhang; Robert J Kurman; Ie-Ming Shih
Journal:  Am J Surg Pathol       Date:  2014-12       Impact factor: 6.394

5.  E-cadherin induces mesenchymal-to-epithelial transition in human ovarian surface epithelium.

Authors:  N Auersperg; J Pan; B D Grove; T Peterson; J Fisher; S Maines-Bandiera; A Somasiri; C D Roskelley
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-25       Impact factor: 11.205

6.  Detection, characterization, and spontaneous differentiation in vitro of very small embryonic-like putative stem cells in adult mammalian ovary.

Authors:  Seema Parte; Deepa Bhartiya; Jyoti Telang; Vinita Daithankar; Vinita Salvi; Kusum Zaveri; Indira Hinduja
Journal:  Stem Cells Dev       Date:  2011-03-23       Impact factor: 3.272

7.  Nuclear entry of activated MAPK is restricted in primary ovarian and mammary epithelial cells.

Authors:  Elizabeth R Smith; Kathy Qi Cai; Jennifer L Smedberg; Melina M Ribeiro; Malgorzata E Rula; Carolyn Slater; Andrew K Godwin; Xiang-Xi Xu
Journal:  PLoS One       Date:  2010-02-18       Impact factor: 3.240

8.  Regulation of miR-200 family microRNAs and ZEB transcription factors in ovarian cancer: evidence supporting a mesothelial-to-epithelial transition.

Authors:  Ausra Bendoraite; Emily C Knouf; Kavita S Garg; Rachael K Parkin; Evan M Kroh; Kathy C O'Briant; Aviva P Ventura; Andrew K Godwin; Beth Y Karlan; Charles W Drescher; Nicole Urban; Beatrice S Knudsen; Muneesh Tewari
Journal:  Gynecol Oncol       Date:  2009-10-24       Impact factor: 5.482

9.  Repertoire of microRNAs in epithelial ovarian cancer as determined by next generation sequencing of small RNA cDNA libraries.

Authors:  Stacia K Wyman; Rachael K Parkin; Patrick S Mitchell; Brian R Fritz; Kathy O'Briant; Andrew K Godwin; Nicole Urban; Charles W Drescher; Beatrice S Knudsen; Muneesh Tewari
Journal:  PLoS One       Date:  2009-04-23       Impact factor: 3.240

10.  Derepression of CLDN3 and CLDN4 during ovarian tumorigenesis is associated with loss of repressive histone modifications.

Authors:  Mi Jeong Kwon; Sung-Su Kim; Yoon-La Choi; Hun Soon Jung; Curt Balch; Su-Hyeong Kim; Yong-Sang Song; Victor E Marquez; Kenneth P Nephew; Young Kee Shin
Journal:  Carcinogenesis       Date:  2010-01-06       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.